{
  "report_rows": [
    {
      "kpi": "Revenue (2026 Q2)",
      "prediction": "IN-LINE",
      "answer": "pred ~$758M vs. cons $752M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA (2026 Q2)",
      "prediction": "BEAT",
      "answer": "pred ~$267M vs. cons $262M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP diluted EPS (2026 Q2)",
      "prediction": "BEAT",
      "answer": "pred ~$0.38 vs. cons $0.37",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Revenue guidance",
      "prediction": "LOWER",
      "answer": "guide ~$795M vs. cons $802M (2026 Q3)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA guidance",
      "prediction": "LOWER",
      "answer": "guide ~$320M vs. cons $328M (2026 Q3)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA margin guidance",
      "prediction": "UNCHANGED",
      "answer": "guide \u226540.0% vs. cons 40.0% (FY 2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -8.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -12.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "The Q2 beat is likely overshadowed by Q3 revenue guidance of ~$795M versus $802M consensus and Q3 adjusted EBITDA guidance of ~$320M versus $328M consensus; the implied out-period cuts should pressure estimates after day 1, extending the residual move from approximately -8.0% to -12.5%.",
  "day5_confidence": "MEDIUM"
}